IL246654B - Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition - Google Patents
Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical compositionInfo
- Publication number
- IL246654B IL246654B IL246654A IL24665416A IL246654B IL 246654 B IL246654 B IL 246654B IL 246654 A IL246654 A IL 246654A IL 24665416 A IL24665416 A IL 24665416A IL 246654 B IL246654 B IL 246654B
- Authority
- IL
- Israel
- Prior art keywords
- acetic acid
- castor oil
- acid compound
- preparation containing
- polyoxyethylene castor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014002809 | 2014-01-10 | ||
| PCT/JP2015/050333 WO2015105134A1 (ja) | 2014-01-10 | 2015-01-08 | ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL246654A0 IL246654A0 (en) | 2016-08-31 |
| IL246654B true IL246654B (en) | 2020-05-31 |
Family
ID=53523959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL246654A IL246654B (en) | 2014-01-10 | 2016-07-07 | Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US20160317512A1 (enExample) |
| EP (2) | EP3888654B1 (enExample) |
| JP (5) | JP6012775B2 (enExample) |
| KR (6) | KR102458180B1 (enExample) |
| CN (2) | CN105828817B (enExample) |
| AU (1) | AU2015205268B2 (enExample) |
| BR (1) | BR112016015911B1 (enExample) |
| CA (1) | CA2934612C (enExample) |
| EA (1) | EA031723B1 (enExample) |
| ES (2) | ES2953346T3 (enExample) |
| GE (1) | GEP20186916B (enExample) |
| IL (1) | IL246654B (enExample) |
| MX (1) | MX2016009058A (enExample) |
| MY (1) | MY166210A (enExample) |
| PH (1) | PH12016501327A1 (enExample) |
| SG (1) | SG11201605532YA (enExample) |
| TW (1) | TWI612960B (enExample) |
| UA (1) | UA121744C2 (enExample) |
| WO (1) | WO2015105134A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3093018T (pt) | 2014-01-10 | 2019-01-10 | Santen Pharmaceutical Co Ltd | Preparação farmacêutica incluindo um composto de ácido piridilaminoacético |
| CA2935055C (en) | 2014-01-10 | 2021-08-24 | Santen Pharmaceutical Co., Ltd. | Pharmaceutical composition containing pyridylaminoacetic acid compound |
| GEP20186916B (en) * | 2014-01-10 | 2018-11-12 | Pharmaceutical Co Ltd Santen | Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition |
| EP3320904B1 (en) | 2015-07-09 | 2023-07-05 | Santen Pharmaceutical Co., Ltd. | Preventative and/or therapeutic agent containing pyridyl aminoacetic acid compound for treating a disease involving a greatly elevated intraocular pressure |
| US20200121652A1 (en) | 2017-06-16 | 2020-04-23 | The Doshisha | Compounds having caspase inhibitory activity, pharmaceutical agent containing said compounds and for treating or preventing corneal endothelial symptoms, disorders, or diseases, and application of said pharmaceutical agent |
| EP3639854A4 (en) | 2017-06-16 | 2021-03-03 | The Doshisha | MTOR INHIBITIVE MEDICINAL PRODUCT FOR THE TREATMENT OR PREVENTION OF OPHTHALMIC SYMPTOMS, DISORDERS, OR DISEASES AND USE THEREOF |
| EP3689349A4 (en) | 2017-09-29 | 2021-06-23 | Santen Pharmaceutical Co., Ltd. | MEDICINAL PRODUCT CONTAINING A COMPOUND OF PYRIDYLAMINOACETIC ACID |
| CA3086445A1 (en) | 2017-12-21 | 2019-06-27 | Santen Pharmaceutical Co., Ltd. | Omidenepag combination |
| WO2019131901A1 (ja) | 2017-12-28 | 2019-07-04 | 参天製薬株式会社 | ピリジルアミノ酢酸化合物を含有する医薬製剤 |
| CN114761022B (zh) * | 2019-11-29 | 2024-02-13 | 千寿制药株式会社 | 药物组合物 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4960799A (en) * | 1988-09-13 | 1990-10-02 | Ciba-Geigy Corporation | Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use |
| US5631287A (en) * | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
| JP3297969B2 (ja) * | 1994-12-26 | 2002-07-02 | ライオン株式会社 | 点眼剤 |
| US6235781B1 (en) * | 1998-07-14 | 2001-05-22 | Alcon Laboratories, Inc. | Prostaglandin product |
| DE69922916T2 (de) * | 1998-07-14 | 2005-06-09 | Alcon Manufacturing Ltd., Fort Worth | Polypropylenbasierte behälter für prostaglandin-enthaltende produkte |
| US20020009507A1 (en) * | 2000-01-19 | 2002-01-24 | Alcon Universal Ltd. | Use of polyethoxylated castor oil for the treatment of dry eye |
| JP2002356420A (ja) * | 2001-03-27 | 2002-12-13 | Santen Pharmaceut Co Ltd | 安定な水性液剤 |
| DK2264009T3 (en) * | 2008-03-12 | 2019-04-15 | Ube Industries | PYRIDYLAMINE ACEDIC ACID COMPOUND |
| PL2415763T3 (pl) | 2009-03-30 | 2016-05-31 | Ube Industries | Kompozycja farmaceutyczna do leczenia lub profilaktyki jaskry |
| JP2011057633A (ja) * | 2009-09-11 | 2011-03-24 | Ube Industries Ltd | ピリジルアミノ酢酸化合物を含有する医薬 |
| US20120058983A1 (en) * | 2010-09-02 | 2012-03-08 | Bayer Pharma Aktiengesellschaft | Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension |
| JP6193655B2 (ja) * | 2012-07-13 | 2017-09-06 | 参天製薬株式会社 | スルホンアミド化合物の組み合わせ |
| JP2014019650A (ja) * | 2012-07-13 | 2014-02-03 | Santen Pharmaceut Co Ltd | スルホンアミド化合物とタフルプロストの組み合わせ |
| US20140018350A1 (en) * | 2012-07-13 | 2014-01-16 | Asahi Glass Co., Ltd. | Combination of sulfonamide compound and tafluprost |
| US9339496B2 (en) * | 2012-07-13 | 2016-05-17 | Santen Pharmaceutical Co., Ltd. | Composition for treating or preventing glaucoma comprising a sulfonamide compound, and a beta-receptor antagonist |
| PT3093018T (pt) * | 2014-01-10 | 2019-01-10 | Santen Pharmaceutical Co Ltd | Preparação farmacêutica incluindo um composto de ácido piridilaminoacético |
| GEP20186916B (en) * | 2014-01-10 | 2018-11-12 | Pharmaceutical Co Ltd Santen | Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition |
| CA2935055C (en) * | 2014-01-10 | 2021-08-24 | Santen Pharmaceutical Co., Ltd. | Pharmaceutical composition containing pyridylaminoacetic acid compound |
-
2015
- 2015-01-08 GE GEAP201514216A patent/GEP20186916B/en unknown
- 2015-01-08 CA CA2934612A patent/CA2934612C/en active Active
- 2015-01-08 CN CN201580003056.5A patent/CN105828817B/zh active Active
- 2015-01-08 BR BR112016015911-0A patent/BR112016015911B1/pt active IP Right Grant
- 2015-01-08 KR KR1020217007751A patent/KR102458180B1/ko active Active
- 2015-01-08 CN CN201910493497.8A patent/CN110251516B/zh active Active
- 2015-01-08 KR KR1020247019428A patent/KR20240096869A/ko not_active Ceased
- 2015-01-08 KR KR1020187012966A patent/KR102111157B1/ko active Active
- 2015-01-08 KR KR1020167016400A patent/KR101858373B1/ko active Active
- 2015-01-08 AU AU2015205268A patent/AU2015205268B2/en active Active
- 2015-01-08 ES ES21174649T patent/ES2953346T3/es active Active
- 2015-01-08 KR KR1020227036348A patent/KR102675685B1/ko active Active
- 2015-01-08 MX MX2016009058A patent/MX2016009058A/es unknown
- 2015-01-08 KR KR1020207013304A patent/KR102230683B1/ko active Active
- 2015-01-08 EA EA201691139A patent/EA031723B1/ru unknown
- 2015-01-08 SG SG11201605532YA patent/SG11201605532YA/en unknown
- 2015-01-08 EP EP21174649.0A patent/EP3888654B1/en active Active
- 2015-01-08 UA UAA201607761A patent/UA121744C2/uk unknown
- 2015-01-08 TW TW104100527A patent/TWI612960B/zh active
- 2015-01-08 EP EP15735607.2A patent/EP3093021B1/en active Active
- 2015-01-08 WO PCT/JP2015/050333 patent/WO2015105134A1/ja not_active Ceased
- 2015-01-08 MY MYPI2016001268A patent/MY166210A/en unknown
- 2015-01-08 JP JP2015002271A patent/JP6012775B2/ja active Active
- 2015-01-08 ES ES15735607T patent/ES2874547T3/es active Active
-
2016
- 2016-07-04 PH PH12016501327A patent/PH12016501327A1/en unknown
- 2016-07-07 US US15/204,475 patent/US20160317512A1/en not_active Abandoned
- 2016-07-07 IL IL246654A patent/IL246654B/en active IP Right Grant
- 2016-09-16 JP JP2016181739A patent/JP6449205B2/ja active Active
-
2018
- 2018-12-05 JP JP2018227964A patent/JP6793172B2/ja active Active
-
2019
- 2019-12-12 US US16/711,706 patent/US20200113880A1/en not_active Abandoned
-
2020
- 2020-11-09 JP JP2020186245A patent/JP7170020B2/ja active Active
-
2022
- 2022-10-31 JP JP2022174719A patent/JP7546027B2/ja active Active
-
2023
- 2023-08-02 US US18/363,961 patent/US20230372316A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL246654B (en) | Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition | |
| EP3362123A4 (en) | MEDICAL LUER CONNECTION | |
| HUE058764T2 (hu) | Gyors hatású inzulin készítmények | |
| EP2968894A4 (en) | MEDICAL CONNECTOR | |
| PL3082706T3 (pl) | Wózek inwalidzki o podniesionej wysokości | |
| BR112016020522A2 (pt) | Limpador interdental | |
| EP2916905A4 (en) | MEDICAL CONNECTOR | |
| EP2842540A4 (en) | MEDICAL CONNECTOR | |
| DK2928533T3 (da) | Medicinske slanger og fremgangsmåder til fremstilling | |
| IL246655A0 (en) | Pharmaceutical composition containing pyridylaminoacetic acid compound | |
| IL246447A0 (en) | Pharmaceutical preparation containing pyridylaminoacetic acid compound | |
| DK2818148T3 (da) | Kørestolslift | |
| ZA201600997B (en) | Quinine compounds, and optical isomers, preparation method and medical use thereof | |
| DK3079655T3 (da) | Inhalerbare lægemidler | |
| HUE062326T2 (hu) | Fokozott stabilitású gyógyászati készítmény | |
| EP3007770A4 (en) | MEDICAL ROBOT | |
| IL252750A0 (en) | Pharmaceutical compositions comprising a pyrazine derivative together with a quinazoline derivative | |
| IL250729B (en) | A pyrazolothiazole compound and a drug containing it | |
| IL249842A0 (en) | Lipid comprising docosapentaenoic acid | |
| DK2897588T3 (da) | Inhalerbart lægemiddel | |
| FI20145982A7 (fi) | Potilasalusta | |
| TH1501005357A (th) | สารประกอบพิแรโซล-เอไมด์ และการใช้ทางการแพทย์ของมัน | |
| FI10021U1 (fi) | Väline lääketieteelliseen kuljetukseen | |
| IL244316A0 (en) | A new composition of a drug | |
| ES1104605Y (es) | Cabecero modular hospitalario |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |